Hubei Goto Biopharm Co.,Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 445.95 million compared to CNY 319.49 million a year ago. Revenue was CNY 445.95 million compared to CNY 319.49 million a year ago.

Net income was CNY 54.07 million compared to CNY 31.29 million a year ago. Basic earnings per share from continuing operations was CNY 0.53 compared to CNY 0.36 a year ago. Diluted earnings per share from continuing operations was CNY 0.53 compared to CNY 0.36 a year ago.